Edition:
India

Depomed Inc (DEPO.OQ)

DEPO.OQ on NASDAQ Stock Exchange Global Select Market

8.31USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$8.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
432,779
52-wk High
$21.37
52-wk Low
$4.32

Select another date:

Tue, Dec 5 2017

BRIEF-Depomed Announces Nucynta® Commercialization Agreement With Collegium Pharmaceutical

* DEPOMED ANNOUNCES NUCYNTA® COMMERCIALIZATION AGREEMENT WITH COLLEGIUM PHARMACEUTICAL

BRIEF-Collegium To License Rights To Commercialize Nucynta Franchise

* COLLEGIUM TO LICENSE RIGHTS TO COMMERCIALIZE NUCYNTA FRANCHISE

BRIEF-Depomed announces Q3 loss of $0.25 per share

* Depomed inc sees ‍2017 non-gaap total revenue $380 to $385 million​

BRIEF-Depomed and Slán Medicinal Holdings announce strategic asset transactions

* Depomed and Slán Medicinal Holdings Ltd announce strategic asset transactions

BRIEF-PDL Biopharma announces settlement agreement with Valeant

* PDL Biopharma - ‍Valeant to pay a one-time, lump-sum payment of $13.0 million as part of settlement

BRIEF-Depomed ‍provides information on impact of hurricane Maria to supply of NUCYNTA ER​

* Says ‍provides information on impact of hurricane Maria to supply of NUCYNTA ER​

BRIEF-Armistice Capital LLC reports 6.4 pct passive stake in Depomed Inc

* Armistice Capital LLC reports 6.4 percent passive stake in Depomed Inc as on August 8, 2017 - SEC filing‍​‍​ Source text (http://bit.ly/2vLa8Uq) Further company coverage:

BRIEF-Depomed Q2 loss per share $0.43

* Q2 earnings per share view $0.09 -- Thomson Reuters I/B/E/S

BRIEF-Depomed announces intent to effect a debt refinancing

* Seeking to refinance its existing $375 million principal amount of privately placed secured senior notes

BRIEF-Depomed chief medical officer Srinivas Rao resigns

* Depomed inc - on june 30, co entered agreement with Srinivas G. Rao, co's chief medical officer, pursuant to which dr. Rao to resign as officer of co Source text for Eikon: Further company coverage:

Select another date: